For example, targeting poly-ADP-ribose polymerase (PARP) markedly increased PD-L1 expression in cancer cells, augmenting the antitumor effect of PD-L1 blockade and cytotoxic T-cell infiltration in gynecologic cancers [10]. The gene discussed is CD274; the disease is female reproductive organ cancer.